Controversies in orthopaedic oncology.

Area of Science:

• Orthopaedic Oncology
• Surgical Oncology
• Bone Sarcoma Research

Background:

• Chondrosarcoma, the second most common surgically treated primary bone sarcoma, presents diagnostic and therapeutic controversies.
• Periprosthetic joint infection (PJI) in oncological reconstructions poses unique management challenges.
• Existing literature lacks sufficient consensus on optimal chondrosarcoma and PJI treatment strategies.

Framework:

• The Birmingham Orthopaedic Oncology Meeting (BOOM) in January 2024 convened 300 international delegates to establish global consensus.
• Focus areas included chondrosarcoma diagnostics, primary tumor treatment, subtypes, complications, and PJI management in oncological reconstructions.
• Consensus statements were generated through evidence amalgamation and diverse expert opinions.

Implementation:

• Debates covered two-stage revisions, antibiotic prophylaxis, acute PJI management during chemotherapy, and wound management strategies.
• Specific attention was given to allograft reconstruction in the context of PJI.
• The meeting aimed to resolve immediate controversies and identify areas for future research.

Implications:

• Fostering global collaboration among orthopaedic oncology specialists.
• Encouraging future research to address unsolved dilemmas in chondrosarcoma and PJI.
• Enhancing treatment standards and improving patient outcomes worldwide through collaborative efforts.